Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with ...
5 Articles
5 Articles


Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with ...
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's future dual…
Beta Bionics to pair iLet with Abbott's dual glucose-ketone sensor
The iLet with the Dexcom G7 (left) and Abbott FreeStyle Libre 3 Plus (right). [Image courtesy of Beta Bionics]Beta Bionics (Nasdaq:BBNX) announced today that it agreed to integrate its iLet bionic pancreas with a future dual sensor from Abbott (NYSE:ABT). The agreement pairs the iLet automated insulin delivery system with the sensor designed to continuously monitor glucose and ketone levels. This marks the third such integration for the Abbott d…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium